Sorrento Therapeutics Inc. (SRNE)

1.53
NASDAQ : Health Technology
Prev Close 1.64
Day Low/High 1.51 / 1.64
52 Wk Low/High 1.39 / 6.50
Avg Volume 1.24M
Exchange NASDAQ
Shares Outstanding 141.87M
Market Cap 232.67M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Sorrento Therapeutics Announces $25 Million Registered Direct Offering

Sorrento Therapeutics Announces $25 Million Registered Direct Offering

SAN DIEGO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc.

Interesting SRNE Call Options For November 15th

Interesting SRNE Call Options For November 15th

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the November 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new November 15th contracts and identified the following call contract of particular interest.

Scilex Holding Announces Confidential Submission Of Draft Registration Statement For Proposed Initial Public Offering

Scilex Holding Announces Confidential Submission Of Draft Registration Statement For Proposed Initial Public Offering

SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc.

Dr. Henry Ji To Participate In Multiple Investment Conferences In September 2019 To Provide Corporate Updates

Dr. Henry Ji To Participate In Multiple Investment Conferences In September 2019 To Provide Corporate Updates

SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc.

First Week Of October 18th Options Trading For Sorrento Therapeutics (SRNE)

First Week Of October 18th Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the October 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new October 18th contracts and identified the following call contract of particular interest.

Interesting SRNE Put And Call Options For March 2020

Interesting SRNE Put And Call Options For March 2020

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the March 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Sorrento Therapeutics Announces Closing Of Underwritten Public Offering Of Common Stock And Warrants

Sorrento Therapeutics Announces Closing Of Underwritten Public Offering Of Common Stock And Warrants

SAN DIEGO, July 02, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable...

First Week Of August 16th Options Trading For Sorrento Therapeutics (SRNE)

First Week Of August 16th Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

First Week Of SRNE July 19th Options Trading

First Week Of SRNE July 19th Options Trading

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

First Week Of December 20th Options Trading For Sorrento Therapeutics (SRNE)

First Week Of December 20th Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the December 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Take a Look at This Relatively Unknown Biopharma

The focus of Sorrento Therapeutics is in oncology, and the treatment of pain associated with cancer.

Interesting SRNE Put Options For February 15th

Interesting SRNE Put Options For February 15th

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new February 15th contracts and identified the following put contract of particular interest.

Interesting SRNE Put Options For October 19th

Interesting SRNE Put Options For October 19th

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new October 19th contracts and identified the following put contract of particular interest.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACC, HNI, OAK, SIM Downgrades: GFED, GROW, SRNE, STCN Initiations: CADE Read on to get TheStreet Quant Ratings' detailed report:

SRNE Crosses Below Key Moving Average Level

SRNE Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Sorrento Therapeutics Inc crossed below their 200 day moving average of $5.66, changing hands as low as $5.40 per share. Sorrento Therapeutics Inc shares are currently trading down about 9% on the day.

Interesting SRNE Put And Call Options For July 20th

Interesting SRNE Put And Call Options For July 20th

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

First Week Of August 17th Options Trading For Sorrento Therapeutics (SRNE)

First Week Of August 17th Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

First Week Of December 21st Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the December 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BDL, SRNE Downgrades: BIG, BSET, GTN.A, INS, ISRL, NICK, SNDX Initiations: PLYA Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: D (Sell)